Dr. David Alan Rizzieri, MD
- Medicare services, 2021
- 232
- Part D claims, 2024
- 32
- Publications
- 2
- Clinical trials
- 1
- Hospital affiliations
- 3
- Practice address
- 2131 South 17th Street, Wilmington, NC 28402
- Practice phone
- Call (910) 667-5619
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
New Hanover Regional Medical Center Rehabilitation - Unit
Acute Care Hospital-Unit · Wilmington, North Carolina
Find Dr. Rizzieri's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Alan Rizzieri is a medical oncologist in Wilmington, North Carolina
Dr. Rizzieri practices at New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina.
Dr. Rizzieri's NPI, 1043346877, was assigned on February 26, 2007. Dr. Rizzieri graduated from University of Rochester School of Medicine and Dentistry in 1991. Dr. Rizzieri holds North Carolina license 9700730.
- NPI
- 1043346877NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0941325500
- NPI enumeration date
- February 26, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (910) 667-5619
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Alan Rizzieri practices at New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina
Dr. Rizzieri's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit, at 2131 South 17th Street, Wilmington, NC 28402 in New Hanover County. The practice phone is (910) 667-5619.
- New Hanover Regional Medical Center Rehabilitation - Unit2131 South 17th Street, Wilmington, NC 28402 · New Hanover CountyPhone(910) 667-5619
Source: Dmand AI Affiliation Data
Dr. David Alan Rizzieri is affiliated with 8 sites of care and 4 medical groups
Dr. Rizzieri's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina. Dr. Rizzieri is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI also links Dr. Rizzieri to 1 more hospital, 3 group practices and clinics, 3 medical groups, 1 behavioral health center and 1 breast imaging center, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. David Alan Rizzieri's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizzieri practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| New Hanover Regional Medical Center Rehabilitation - Unit | Available with a free account |
| +7 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Alan Rizzieri is one of 203 medical oncologists in North Carolina
Medical oncology is Dr. Rizzieri's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Rizzieri is licensed in North Carolina.
Specialties and state licenses
- Medical oncology, North CarolinaPrimary
Medical oncologists near Dr. Rizzieri
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Alan Rizzieri billed Medicare for 232 services in 2021
CMS data shows 232 Medicare services from Dr. Rizzieri across 4 procedure codes in 2021. Medicare paid $20,542 for them.
Dr. Rizzieri's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 3652021: 23236%
Where Dr. Rizzieri's Medicare services took place, 2021
- In an office6327%
- In a facility16973%
Dr. Rizzieri compared with the North Carolina median for medical oncologists, 2021
- Dr. Rizzieri
- North Carolina median
- Medicare services
- 232vs 52556% below
- Part D claims
- 12vs 36797% below
Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Rizzieri's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rizzieri?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rizzieri and other medical oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David Alan Rizzieri's patients have a median age of 73
Across all payers, Dmand AI patient panel data puts Dr. Rizzieri's median patient age at 73, with 50% women.
Dr. Rizzieri's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. David Alan Rizzieri wrote 32 Medicare Part D claims in 2024
In 2024, Dr. Rizzieri wrote 32 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $41 in total drug cost. In 2020, CMS named 53 claims across 4 drugs.
Dr. Rizzieri's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rizzieri's Part D claims, 2024
- Antibiotics41%13 of 32 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2020 to 2024
- 2020
- 2024
- Claims for drugs CMS names
- 2020: 532024: 1277%
Drugs named by CMS: 1 in 2024, 4 in 2020.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. David Alan Rizzieri takes part in Medicare
Dr. Rizzieri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David Alan Rizzieri has 2 publications on record
Dmand AI links 2 papers to Dr. Rizzieri in 2025. 2025 was the busiest year, with 2. Dr. Rizzieri's most frequent co-authors are Frederick R. Appelbaum, Ruthee-Lu Bayer, MD and Jeffrey Warren Chell, MD.
Dr. Rizzieri's most frequent co-authors
- Frederick R. Appelbaum1 shared paper
- Ruthee-Lu Bayer, MD1 shared paper
- Jeffrey Warren Chell, MD1 shared paper
Recent publications by Dr. Rizzieri
See who Dr. Rizzieri researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rizzieri works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Alan Rizzieri has worked on 1 clinical trial
Dmand AI links Dr. Rizzieri to 1 clinical trial. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid. Open Payments lists research payments to Dr. Rizzieri that name 1 trial.
Conditions in Dr. Rizzieri's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
Investigators on the most trials with Dr. Rizzieri
Recent clinical trials with Dr. Rizzieri
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Alan Rizzieri received $1,294,935 in industry payments from 2016 to 2025
CMS Open Payments shows 891 general payments to Dr. Rizzieri from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Incyte Corporation paid the most, $615,692. It also lists 5 research payments totaling $23,395 from 2016 to 2017, naming 1 clinical trial.
General payments to Dr. Rizzieri by program year, 2016 to 2025
General payments to Dr. Rizzieri by kind, 2016 to 2025
- Speaker and faculty fees$871,82467%
- Consulting fees$211,19316%
- Travel and lodging$146,09411%
- Honoraria$45,3674%
- Other$20,3712%
Companies that paid Dr. Rizzieri the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David Alan Rizzieri graduated from University of Rochester School of Medicine and Dentistry
Dr. Rizzieri graduated from University of Rochester School of Medicine and Dentistry in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. David Alan Rizzieri's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Alan Rizzieri
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Alan Rizzieri's NPI number?
Dr. David Alan Rizzieri's NPI number is 1043346877. It was assigned on February 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. David Alan Rizzieri?
Dr. David Alan Rizzieri is a medical oncologist in Wilmington, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. David Alan Rizzieri practice?
Dr. Rizzieri practices at 2131 South 17th Street, Wilmington, NC 28402. Dr. Rizzieri's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina. Dmand AI also links Dr. Rizzieri to 1 hospital, 3 group practices and clinics, 3 medical groups, 1 behavioral health center and 1 breast imaging center.
What is Dr. David Alan Rizzieri's office phone number?
The practice phone on file for Dr. Rizzieri is (910) 667-5619.
What is Dr. David Alan Rizzieri's medical license number?
Dr. Rizzieri holds North Carolina license 9700730.
Which hospitals is Dr. David Alan Rizzieri affiliated with?
Dr. Rizzieri is affiliated with Novant Health New Hanover Regional Medical Center. Dmand AI links Dr. Rizzieri to 2 more hospitals.
What medical group is Dr. David Alan Rizzieri part of?
Dr. Rizzieri is linked to Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI links Dr. Rizzieri to 3 more medical groups.
Does Dr. David Alan Rizzieri accept Medicare?
Yes. CMS data shows Dr. Rizzieri billed Medicare for 232 services in 2021, and Dr. Rizzieri accepts Medicare assignment.
What services does Dr. David Alan Rizzieri bill to Medicare?
In 2021, Dr. Rizzieri's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, new patient (99205).
Where did Dr. David Alan Rizzieri go to medical school?
Dr. Rizzieri graduated from University of Rochester School of Medicine and Dentistry in 1991.
Show 5 more questionsShow fewer questions
What drugs does Dr. David Alan Rizzieri prescribe most?
In 2024 Medicare Part D data, Dr. Rizzieri's most prescribed drugs by claims were Sulfamethoxazole-Trimethoprim.
Has Dr. David Alan Rizzieri received payments from drug or device companies?
CMS Open Payments shows $1,294,935 in general payments to Dr. Rizzieri from 32 companies from 2016 to 2025. The largest total came from Incyte Corporation.
How long has Dr. David Alan Rizzieri been practicing?
Dr. Rizzieri graduated from medical school in 1991, 35 years ago.
Does Dr. David Alan Rizzieri do research?
Dmand AI links 2 publications to Dr. Rizzieri. Dr. Rizzieri has worked on 1 clinical trial.
Who does Dr. David Alan Rizzieri publish with?
Dr. Rizzieri's most frequent co-authors are Frederick R. Appelbaum (1 shared paper), Ruthee-Lu Bayer, MD (1 shared paper) and Jeffrey Warren Chell, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card